Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • bioAffinity Technologies' Shares Outstanding (Weighted Average) rose 15823.61% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 15823.61%. This contributed to the annual value of $12.1 million for FY2024, which is 3861.12% up from last year.
  • Per bioAffinity Technologies' latest filing, its Shares Outstanding (Weighted Average) stood at $1.1 million for Q3 2025, which was up 15823.61% from $24.0 million recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Shares Outstanding (Weighted Average) high stood at $24.0 million for Q2 2025, and its period low was $412936.0 during Q3 2024.
  • For the 4-year period, bioAffinity Technologies' Shares Outstanding (Weighted Average) averaged around $8.2 million, with its median value being $8.5 million (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 21634.23% in 2023, then crashed by 9525.17% in 2024.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Shares Outstanding (Weighted Average) stood at $4.5 million in 2022, then surged by 94.43% to $8.7 million in 2023, then skyrocketed by 38.61% to $12.1 million in 2024, then tumbled by 91.21% to $1.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.1 million for Q3 2025, versus $24.0 million for Q2 2025 and $16.3 million for Q1 2025.